Sunday, Dec 15, 2019
engineered enzymes for better healthcare

 

Galactosaemia (GAL) results from a deficiency in the enzyme needed to metabolise galactose (a component of milk sugar) and occurs in about 1 in every 40,000 newborns. The incidence in the Irish travellers’ community is 1 in every 450. Newborns with GAL typically appear normal. However within a few days after initiating milk feeding, vomiting, lethargy, diarrhoea, jaundice and liver damage develops. The disorder may result in developmental retardation, growth failure, cataracts and in severe cases death. With early detection and strict galactose-free diet, infants diagnosed with GAL can achieve satisfactory general health.

Product Info

 

amino acid disorders productEnzyme Deficiency Disorders

GAL      Galactosaemia

G6PD    Glucose-6P Dehydrogenase Deficiency

BIO       Biotinidase Deficiency

 

Language Selection

Search